Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical pharmacokinetics of nitroxoline.

A Mrhar, Z Kopitar, F Kozjek

    International Journal of Clinical Pharmacology and Biopharmacy
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    UGT1A1*28 polymorphism influences glucuronidation of bazedoxifene.

    Die Pharmazie·2015
    Same author

    Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2014
    Same author

    The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2012
    Same author

    Mucoadhesion on urinary bladder mucosa: the influence of sodium, calcium, and magnesium ions.

    Die Pharmazie·2010
    Same author

    Enhanced permeability of the urinary bladder wall: the role of polymer charge.

    Die Pharmazie·2009
    Same author

    Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.

    International journal of clinical practice·2007

    This study tracked nitroxoline distribution in rats and humans using radiolabeling and spectrophotometry. A pharmacokinetic model was developed and validated to understand nitroxoline

    Area of Science:

    • Pharmacokinetics and Drug Metabolism
    • Radiopharmaceutical Distribution Studies
    • Analytical Chemistry in Pharmacology

    Background:

    • Nitroxoline is an antimicrobial agent requiring pharmacokinetic evaluation.
    • Understanding drug distribution and metabolism is crucial for therapeutic efficacy.
    • Previous studies may lack comprehensive pharmacokinetic profiling.

    Purpose of the Study:

    • To investigate the pharmacokinetic profile of nitroxoline in rats and humans.
    • To determine the distribution, plasma, and bile levels of nitroxoline.
    • To develop and validate a pharmacokinetic model for nitroxoline.

    Main Methods:

    • Oral administration of 14C-Nitroxoline to rats with autoradiography and radioactivity measurements.
    • Oral and intravenous administration of nitroxoline to human volunteers.

    Related Experiment Videos

  • Spectrophotometric determination of unconjugated and conjugated nitroxoline in urine.
  • Pharmacokinetic modeling using analog-hybrid computer simulation.

    • Main Results:

    • Autoradiographic and radioactivity measurements revealed nitroxoline distribution in rats.
    • Plasma and bile levels of nitroxoline were quantified in animal models.
    • Urine concentrations of nitroxoline (unconjugated and conjugated) were measured in humans.
    • A validated pharmacokinetic model was established based on experimental data.

    Conclusions:

    • The study successfully elucidated the pharmacokinetic behavior of nitroxoline.
    • The developed model accurately represents nitroxoline's disposition in the body.
    • This research provides essential data for optimizing nitroxoline's clinical use.